Literature DB >> 15019233

Biological significance of the U residue at the -3 position of the mRNA sequences of influenza A viral segments PB1 and NA.

Yasuko Maeda1, Hideo Goto, Taisuke Horimoto, Ayato Takada, Yoshihiro Kawaoka.   

Abstract

The levels of viral proteins in infected cells are thought to be regulated by a variety of mechanisms. The initiation codons for the PB1 and NA proteins of A/WSN/33 (H1N1) influenza virus are in a suboptimal Kozak sequence for translation. To determine the significance of these suboptimal Kozak sequences, model vRNAs, whose coding regions were replaced with the reporter SEAP gene (for secreted alkaline phosphatase) and recombinant viruses with optimal Kozak sequences for PB1 and NA were constructed. Conversion of the upstream sequence of the PB1 and NA initiation codon to an optimal Kozak sequence was reflected in the level of reporter protein expression, but not the level of PB1 and NA protein expression. The recombinant viruses that had optimal Kozak sequences for PB1, NA, or both genes had similar replicative properties, both in cell culture and in mice, to those of the wild-type virus. These results suggest that expression of the PB1 and NA proteins is regulated by a mechanism other than that controlling the initiation of translation of these proteins.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15019233     DOI: 10.1016/j.virusres.2003.11.013

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  9 in total

1.  Identification of novel influenza A virus proteins translated from PA mRNA.

Authors:  Yukiko Muramoto; Takeshi Noda; Eiryo Kawakami; Ramesh Akkina; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2012-12-12       Impact factor: 5.103

2.  Live bivalent vaccine for parainfluenza and influenza virus infections.

Authors:  Yasuko Maeda; Masato Hatta; Ayato Takada; Tokiko Watanabe; Hideo Goto; Gabriele Neumann; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

3.  Interactions between Influenza A Virus Nucleoprotein and Gene Segment Untranslated Regions Facilitate Selective Modulation of Viral Gene Expression.

Authors:  Meghan Diefenbacher; Timothy J C Tan; David L V Bauer; Beth M Stadtmueller; Nicholas C Wu; Christopher B Brooke
Journal:  J Virol       Date:  2022-04-25       Impact factor: 6.549

4.  Limited compatibility between the RNA polymerase components of influenza virus type A and B.

Authors:  Kiyoko Iwatsuki-Horimoto; Yasuko Hatta; Masato Hatta; Yukiko Muramoto; Hualan Chen; Yoshihiro Kawaoka; Taisuke Horimoto
Journal:  Virus Res       Date:  2008-05-02       Impact factor: 3.303

5.  N-Terminal Acetylation by NatB Is Required for the Shutoff Activity of Influenza A Virus PA-X.

Authors:  Kohei Oishi; Seiya Yamayoshi; Hiroko Kozuka-Hata; Masaaki Oyama; Yoshihiro Kawaoka
Journal:  Cell Rep       Date:  2018-07-24       Impact factor: 9.423

6.  Overlapping signals for translational regulation and packaging of influenza A virus segment 2.

Authors:  Helen M Wise; Cyril Barbezange; Brett W Jagger; Rosa M Dalton; Julia R Gog; Martin D Curran; Jeffery K Taubenberger; Emma C Anderson; Paul Digard
Journal:  Nucleic Acids Res       Date:  2011-06-21       Impact factor: 16.971

7.  A complicated message: Identification of a novel PB1-related protein translated from influenza A virus segment 2 mRNA.

Authors:  Helen M Wise; Agnes Foeglein; Jiechao Sun; Rosa Maria Dalton; Sheetal Patel; Wendy Howard; Emma C Anderson; Wendy S Barclay; Paul Digard
Journal:  J Virol       Date:  2009-06-03       Impact factor: 5.103

8.  Non coding extremities of the seven influenza virus type C vRNA segments: effect on transcription and replication by the type C and type A polymerase complexes.

Authors:  Bernadette Crescenzo-Chaigne; Cyril Barbezange; Sylvie van der Werf
Journal:  Virol J       Date:  2008-10-30       Impact factor: 4.099

9.  Establishment of a Reverse Genetic System from a Bovine Derived Influenza D Virus Isolate.

Authors:  Melle Holwerda; Laura Laloli; Manon Wider; Lutz Schönecker; Jens Becker; Mireille Meylan; Ronald Dijkman
Journal:  Viruses       Date:  2021-03-18       Impact factor: 5.048

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.